Dopamine receptor functions: lessions from knockout mice

被引:61
作者
Glickstein, SB
Schmauss, C
机构
[1] Columbia Univ, Dept Psychiat Neurosci, New York, NY 10032 USA
[2] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
关键词
gene targeting; dopamine; dopamine receptors; striatum; immediate early genes; heteroligomers;
D O I
10.1016/S0163-7258(01)00145-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the past few years, a number of laboratories have used gene targeting via homologous recombination to generate mice deficient for key molecules involved in dopaminergic (DAergic) transmission. This tremendous effort has resulted in the successful generation and characterization of mice deficient for the neurotransmitter DA, the main terminator of DAergic neurotransmission (the DA transporter), and all five subtypes of DA receptors. This review summarizes the results from studies of the various DA receptor knockout mice and of mice deficient in proteins that mediate DA receptor signaling. It focuses on a comparison of the locomotor phenotypes and responses to drugs of abuse (psychostimulants), and reviews the results of anatomic studies examining the morphological and neurochemical differentiation of the striatum in these mutants. Moreover, an overview of recently published results highlighting the physiological relevance of the interaction between different DA receptors and between DA receptors and other neurotransmitter receptors in the modulation of behavioral and molecular responses to DAergic stimulation is presented. Finally, in view of the recently discovered heteroligomeric assemblies of neurotransmitter receptors that involve DA receptor subtypes, the potential value of knockout mice as a tool for testing the in vivo significance of these heteroligomeric receptors is discussed. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:63 / 83
页数:21
相关论文
共 107 条
[1]   A targeted mutation of the D-3 dopamine receptor gene is associated with hyperactivity in mice [J].
Accili, D ;
Fishburn, CS ;
Drago, J ;
Steiner, H ;
Lachowicz, JE ;
Park, BH ;
Gauda, EB ;
Lee, EJ ;
Cool, MH ;
Sibley, DR ;
Gerfen, CR ;
Westphal, H ;
Fuchs, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1945-1949
[2]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[3]   EXTENSIVE COOCCURRENCE OF SUBSTANCE-P AND DYNORPHIN IN STRIATAL PROJECTION NEURONS - AN EVOLUTIONARILY CONSERVED FEATURE OF BASAL GANGLIA ORGANIZATION [J].
ANDERSON, KD ;
REINER, A .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 295 (03) :339-369
[4]   Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist [J].
Aoyama, S ;
Kase, H ;
Borrelli, E .
JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5848-5852
[5]   Striatal excitatory amino acid receptor subunit expression in the D1A-dopamine receptor-deficient mouse [J].
Ariano, MA ;
Drago, J ;
Sibley, DR ;
Levine, MS .
DEVELOPMENTAL NEUROSCIENCE, 1998, 20 (2-3) :237-241
[6]   Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice [J].
Asa, SL ;
Kelly, MA ;
Grandy, DK ;
Low, MJ .
ENDOCRINOLOGY, 1999, 140 (11) :5348-5355
[7]   PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[8]   Mice deficient in Golf are anosmic [J].
Belluscio, L ;
Gold, GH ;
Nemes, A ;
Axel, R .
NEURON, 1998, 20 (01) :69-81
[9]   Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking [J].
Benjamin, J ;
Li, L ;
Patterson, C ;
Greenberg, BD ;
Murphy, DL ;
Hamer, DH .
NATURE GENETICS, 1996, 12 (01) :81-84
[10]   Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice [J].
Boulay, D ;
Depoortere, R ;
Rostene, W ;
Perrault, G ;
Sanger, DJ .
NEUROPHARMACOLOGY, 1999, 38 (04) :555-565